Шифр: AS12/2008/15/1 Журнал 2008р. Vol. 15 N 1 Nicholl, Michael. Is Routine Use of Sentinel Node Biopsy Justified in Colon Cancer? / Michael Nicholl, Anton J. Bilchik. - P.1-3 Raut, Chandrajit P. Prognostic Factors for Primary GIST: Prime Time for Personalized Therapy? / Chandrajit P. Raut, Ronald P. DeMatteo. - P.4-6 Hemming, Alan W. Heading in the Right Direction: Improved Outcome of Surgery for Advanced Colorectal Liver Metastases / Alan W. Hemming. - P.7-8 Sandoval, Bernardo. Adjuvant Therapy after Resection of Hepatic Colorectal Metastases / Bernardo Sandoval, Yuman Fong. - P.9-10 Curley, Steven A. Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial? / Steven A. Curley. - P.11-13 Greene, Frederick L. Is Case Volume the Only Surrogate for Oncologic Surgical Quality? / Frederick L. Greene. - P.14-15 Lagios, Michael D. Ductal Carcinoma in Situ: Through a Glass, Darkly / Michael D. Lagios, Melvin J. Silverstein. - P.16-17 Levenback, Charles F. Status of Sentinel Lymph Node Biopsy in Gynecological Cancers / Charles F. Levenback. - P.18-20 Fatouros, Michael. The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations / Michael Fatouros, Georgios Baltoyiannis, Dimitrios H. Roukos. - P.21-33 Weber, Randal S. Anemia and Transfusions in Patients Undergoing Surgery for Cancer / Randal S. Weber, Nicolas Jabbour, Robert C.G. Martin. - P.34-45 Sentinel Lymph Node Evaluation Does Not Improve Staging Accuracy in Colon Cancer. - P.46-51 Surgically Managed Gastrointestinal Stromal Tumors: A Comparative and Prognostic Analysis. - P.52-59 Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis. - P.60-68 Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) is an Independent Prognostic Indicator of Worse Outcome in Gastric Cancer Patients. - P.69-79 High-Volume versus Low-Volume for Esophageal Resections for Cancer: The Essential Role of Case-Mix Adjustments based on Data Clinical. - P.80-87 A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer. - P.88-95 Activin A Causes Cancer Cell Aggressiveness in Esophageal Squamous Cell Carcinoma Cells. - P.96-103 Clinicopathologic Features of Superficial Esophageal Cancer: Results of Consecutive 100 Patients. - P.104-116 Laparoscopic Resection of Abdominal Neuroblastoma. - P.117-124 Survival and Health Outcomes After Cytoreductive Surgery With Intraperitoneal Hyperthermic Chemotherapy for Disseminated Peritoneal Cancer of Appendiceal Origin. - P.125-133 Improved Long-Term Outcome of Surgery for Advanced Colorectal Liver Metastases: Reasons and Implications for Management on the Basis of a Severity Score. - P.134-143 Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?. - P.144-157 A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903. - P.158-164 Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis. - P.165-174 Variations in Surgical Treatment and Outcomes of Patients With Pancreatic Cancer: A Population-Based Study. - P.175-185 Second-Look Operation for Unresectable Pancreatic Ductal Adenocarcinoma at a High-Volume Center. - P.186-192 Noninvasive Pancreatic Cystic Neoplasms can be Safely and Effectively Treated by Limited Pancreatectomy. - P.193-198 Treatment Guidelines for Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: When Can We Operate or Observe?. - P.199-205 Zyromski, Nicholas J. Pancreaticoduodenectomy for Cancer: Technical Aspects of the Retroperitoneal Soft Tissue Dissection to Maximize a Negative Surgical Margin / Nicholas J. Zyromski, Thomas J. Howard. - P.206 Long-Term Results of Liver Resection for Non-colorectal, Non-neuroendocrine Metastases. - P.207-218 Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure. - P.219-226 Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery. - P.227-232 Right Hemihepatectomy for Metastatic Cloacogenic Carcinoma using the Staple Technique. - P.233-234 Clinical Outcome after Selective Treatment of Patients Diagnosed with Ductal Carcinoma In Situ of the Breast. - P.235-243 Development of New Cancers in Patients with DCIS: The M.D. Anderson Experience. - P.244-249 The Critical Role of Axillary Ultrasound and Aspiration Biopsy in the Management of Breast Cancer Patients with Clinically Negative Axilla. - P.250-255 Sentinel Node Positivity Rates With and Without Frozen Section for Breast Cancer. - P.256-261 Morbidity in Breast Cancer Patients with Sentinel Node Metastases Undergoing Delayed Axillary Lymph Node Dissection (ALND) Compared with Immediate ALND. - P.262-267 Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma In Situ. - P.268-273 Desmoid Tumors (Fibromatoses) of the Breast: A 25-Year Experience. - P.274-280 A Significant Correlation between Nuclear CXCR4 Expression and Axillary Lymph Node Metastasis in Hormonal Receptor Negative Cancer Breast. - P.281-285 Combined [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Detection of Recurrent, 131I-Negative Thyroid Cancer. - P.286-292 Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?. - P.293-301 Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors). - P.302-309 N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma. - P.310-315 Primary Cutaneous Melanoma with Regression Does not Require a Lower Threshold for Sentinel Lymph Node Biopsy. - P.316-322 Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. - P.323-332 Should Pelvic and Para-aortic Lymphadenectomy Be Different Depending on Histological Subtype in Epithelial Ovarian Cancer?. - P.333-338 Pharmacokinetics of Oxaliplatin During Open Versus Laparoscopically Assisted Heated Intraoperative Intraperitoneal Chemotherapy (HIPEC): An Experimental Study. - P.339-344 "Telangiectatic" Transformation in Soft Tissue Sarcomas. A Clinicopathology Analysis of an Aggressive Feature of High-grade Sarcomas. - P.345-354 Predictors of Complications and Outcomes of External Hemipelvectomy Wounds: Account of 160 Consecutive Cases. - P.355-363 Preservation of the Internal Jugular Vein in the Radical Treatment of Node-Positive Neck - Is It Safe?. - P.364-370 Microsurgical Tissue Transfers for Head and Neck Reconstruction in Patients with Alcohol-Induced Mental Disorder. - P.371-377 Toniato, Antonio. The Negative Sestamibi Scan: Is a Minimally Invasive Parathyroidectomy Still Possible? / Antonio Toniato, Dario Casara, Mariarosa Pelizzo. - P.378-379 Chen, Herbert. Author Reply / Herbert Chen. - P.380-381 Liakakos, Theodore. Peritoneal Recurrence for Gastric Cancer: Can It Be Prevented? / Theodore Liakakos. - P.382 Namazi, Hamid. Practice Pearl: A Novel Use of Tranexamic Acid for Decreasing the Blood Loss of Aneurysmal Bone Cyst Ablation / Hamid Namazi, Kamran Mozaffarian. - P.383-384 Liakakos, Theodore. Does Lymphadenectomy Improve Survival of Patients with Solid Tumors? / Theodore Liakakos, Dimitrios H. Roukos. - P.385 Ziogas, Dimosthenis. Lymphadenectomy in Surgical Oncology / Dimosthenis Ziogas, Georgios Baltogiannis, Michael Fatouros. - P.386-387 Gervasoni, James E. Response to Letters-to-the-Editor: Role of Lymphadenectomy in Solid Tumors - An Update on the Clinical Data / James E. Gervasoni, Samer Sbayi, Blake Cady. - P.388-389 Axillary Reverse Mapping in Breast Cancer: Can we Spare what we Find?. - P.390-391 Comments to the Letter to the Editor by Dr. Ponzone. - P.392-393 Є примірники у відділах: всього 1 : ВКТ (1) Вільні: ВКТ (1) |